Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Cancers
|
December 13, 2016
The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance
Bridget T Kreger, Eric R Johansen, Richard A Cerione, et al.
The Journal of Biological Chemistry
|
July 22, 2016
Microvesicle Cargo and Function Changes upon Induction of Cellular Transformation
Bridget T Kreger, Andrew L Dougherty, Kai Su Greene, et al.
Science Signaling
|
May 26, 2011
α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1
Mark R Silvis, Bridget T Kreger, Wen-Hui Lien, et al.
Cell
|
March 8, 2011
Yap1 acts downstream of α-catenin to control epidermal proliferation
Karin Schlegelmilch, Morvarid Mohseni, Oktay Kirak, et al.
Cancer Research
|
October 28, 2025
CFT1946 is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader that Overcomes BRAF Inhibitor Resistance
Bridget T Kreger, Yanke Liang, Nicole M Reilly, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Cancers
|
December 13, 2016
The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance
Bridget T Kreger, Eric R Johansen, Richard A Cerione, et al.
The Journal of Biological Chemistry
|
July 22, 2016
Microvesicle Cargo and Function Changes upon Induction of Cellular Transformation
Bridget T Kreger, Andrew L Dougherty, Kai Su Greene, et al.
Science Signaling
|
May 26, 2011
α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1
Mark R Silvis, Bridget T Kreger, Wen-Hui Lien, et al.
Cell
|
March 8, 2011
Yap1 acts downstream of α-catenin to control epidermal proliferation
Karin Schlegelmilch, Morvarid Mohseni, Oktay Kirak, et al.
Cancer Research
|
October 28, 2025
CFT1946 is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader that Overcomes BRAF Inhibitor Resistance
Bridget T Kreger, Yanke Liang, Nicole M Reilly, et al.
Page
of 1